Allena Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Allena Pharmaceuticals

11/11/2021 24:50

* Allena Pharmaceuticals Inc  ALNA.OQ  reported a quarterly
adjusted loss of 17 cents​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 18 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Allena Pharmaceuticals Inc's reported EPS for the quarter was
a loss of 17 cents​.
* The mean earnings estimate of analysts had fallen by
about 2.8% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Allena Pharmaceuticals Inc shares had risen by 6.3% this
quarter and lost 25.0% so far this year.
* The company reported a quarterly loss of $12.69 million.
* Wall Street's median 12-month price target for Allena
Pharmaceuticals Inc is $4.75 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 12:50 a.m.
 ​All figures in US dollars unless otherwise stated